Text Size
81 studies found for:    "Pneumonia, Bacterial"

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
"Pneumonia, Bacterial" (81 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia
Condition: Pneumonia, Bacterial
Intervention: Drug: Ciprofloxacin (Cipro, BAYQ3939)
2 Completed Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia
Condition: Pneumonia, Bacterial
Intervention: Drug: daptomycin
3 Completed A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
Condition: Pneumonia, Bacterial
Interventions: Drug: Beta-Lactam;   Drug: Ceftriaxone
4 Suspended A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia
Conditions: Pneumonia, Bacterial;   Community-Acquired Infections;   Nosocomial Infection;   Pneumonia, Ventilator-Associated
Interventions: Drug: cefepime placebo;   Drug: cefepime;   Drug: doripenem;   Drug: doripenem placebo
5 Recruiting Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
Conditions: Pneumonia, Bacterial;   Community-acquired
Interventions: Drug: Ceftaroline;   Drug: Levofloxacin
6 Completed Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae
Condition: Pneumonia, Bacterial
Intervention: Drug: daptomycin
7 Terminated Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia (CABP)
Interventions: Drug: JNJ-32729463;   Drug: moxifloxacin;   Drug: JNJ-32729463 (Open-Label)
8 Completed Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia
Interventions: Drug: Levofloxacin;   Drug: CEM-101
9 Recruiting A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia
Conditions: Community-Acquired Bacterial Pneumonia;   Lung Infection of Individual Not Recently Hospitalized
Interventions: Drug: Ceftaroline;   Drug: Ceftriaxone
10 Recruiting Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial Pneumonia
Interventions: Drug: Solithromycin;   Drug: Moxifloxacin
11 Withdrawn Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia (CABP)
Intervention: Drug: Ceftaroline fosamil
12 Completed A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
Conditions: Pneumonia, Bacterial;   Nosocomial Infection;   Intraabdominal Infections;   Urinary Tract Infection
Intervention: Drug: No intervention
13 Completed Five Versus Seven Day Antibiotic Course for the Treatment of Pneumonia in the Intensive Care Unit
Condition: Pneumonia, Bacterial
Interventions: Other: 5 Days of Antibiotics;   Other: 7 Days of Antibiotics therapy for pneumonia
14 Recruiting Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
Conditions: Pneumonia, Bacterial;   Pneumonia, Viral;   Meningitis, Bacterial
Intervention:
15 Unknown † Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children
Conditions: Viral Pneumonia;   Bacterial Pneumonia
Intervention:
16 Completed
Has Results 		The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)
Condition: Pneumonia, Bacterial
Intervention: Drug: ampicillin sodium/sulbactam sodium
17 Recruiting Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia
Condition: Community Acquired Bacterial Pneumonia
Intervention: Drug: Efficacy of ceftaroline
18 Completed A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization
Condition: Pneumonia, Bacterial
Interventions: Drug: sulopenem and PF-03709270;   Drug: Sulopenem and PF-03709270;   Drug: Ceftriaxone and amoxicillin/clavulanate
19 Unknown † Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii
Conditions: Cross Infection;   Pneumonia, Bacterial
Interventions: Drug: Colistin;   Drug: Colistin and saline solution
20 Completed Outcomes of Patients Not Responding to Antibiotics in the Community
Conditions: Sinusitis;   Bronchitis, Chronic;   Pneumonia, Bacterial
Interventions: Drug: all macrolide antibiotics;   Drug: all beta-lactam antibiotics
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years